Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
USE CASES
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
PatSnap Eureka Desktop
NEWAnalytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
NEWServices professionnels
Cabinets d'avocats
Sciences de la vie
Haute technologie
Competitor Tech Research
Design Risk Screening
Telecom SEP Claim Chart
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport Explore the ADPKD drug pipeline: mTOR inhibitors, vasopressin V2 receptor antagonists, anti-miR-17 oligonucleotides, and CFTR modulation strategies shaping PKD treatment.
Article | Rapport Mapping the 2026 AFM patent landscape: sub-10 nm chemical imaging, semiconductor metrology, AI automation, and the assignees shaping the next frontier.
Article | Rapport RNA splicing correction and small molecule approaches in the DM1 drug pipeline: ASOs, PPMOs, muscle-targeted conjugates, AAV-RNAi, and MSI2 inhibitors analysed from patent data.
Article | Rapport Atmospheric vs. low-pressure electrolysis for green hydrogen: patent intelligence on compressor elimination, SPE membranes, and >80 bar electrochemical processes.
Article | Rapport Patent signals reveal five innovation clusters shaping VIP technology in 2026 — from glass-substrate glazing to predictive monitoring. Explore the full landscape.
Article | Rapport How does thermophotovoltaic (TPV) energy conversion work, and where is it applied in industrial waste heat recovery? A patent-data deep dive.
Article | Rapport How does thermophotovoltaic (TPV) energy conversion work, and where is it applied in industrial waste heat recovery? A patent-data deep dive covering key players, materials, and system architectures.
Article | Rapport Analyse the ovarian cancer drug pipeline: PARP inhibitor combinations, ADC strategies targeting TROP2 and FRα, and next-generation selective PARP1 inhibitor approaches.
Article | Rapport How does iridium oxide degrade in PEM electrolyzer anodes? Discover the five key mechanisms—dissolution, phase change, interfacial failure, support corrosion, and ionomer encapsulation—from patent analysis.
Article | Rapport Explore the microwave photonics technology landscape in 2026: where RF engineering meets photonics for 5G/6G, radar beamforming, and chip-scale integration.
Article | Rapport How does iridium oxide degrade in PEM electrolyzer anodes? A patent-backed analysis of dissolution, phase change, interfacial failure, and support corrosion mechanisms.
Article | Rapport ADCs, PD-1/PD-L1 checkpoint inhibitors, and HER2-targeted therapies are reshaping the endometrial cancer drug pipeline. Explore the latest patent signals and clinical translation data.
Article | Rapport A 2026 patent landscape of dielectric elastomer actuator technology: materials breakthroughs, structural architectures, self-sensing, and key assignees shaping the DEA field.
Article | Rapport Dry electrode manufacturing eliminates toxic NMP solvents and enables scalable solid-state batteries. Explore key process challenges, patent trends, and leading innovators.
Article | Rapport Anti-PLA2R, felzartamab, obinutuzumab, and BTK inhibitors are reshaping the primary membranous nephropathy drug pipeline. Explore patent signals and clinical data.